UNSPSC 51152058: Fenyripol hydrochloride

This classification denotes a muscle relaxant with the molecular formula C12H13N3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R4I084C0NO, chemically known as benzyl alcohol, alpha-((2-pyrimidinylamino)methyl)-, monohydrochloride but more generally known as fenyripol hydrochloride, which bears US NIH Compound Identifier 17118. Most nations, for tariff and trade purposes, schedule fenyripol hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, FENYRIPOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Fenyripol hydrochloride bears US NLM identifiers UMLS ID C2825401 and NCI Concept Code C80984. SMILES: C1CCC(CC1)C(CNC2NCCCN2)O.CL.

UNSPSC 51152058 Fenyripol hydrochloride is a Commodity code with no relevant recent state and local procurement activity. The two recent opportunities tagged under this code—Seminole County's IFB for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs—do not represent purchases of fenyripol hydrochloride itself. The naloxone solicitation seeks finished pharmaceutical products and harm-reduction equipment unrelated to fenyripol; the Texas HHS RFI addresses pharmacy program administration and direct contracting models, not specific active pharmaceutical ingredients. The code designation appears to reflect a taxonomy mismatch rather than actual procurement intent under the fenyripol commodity.

State and local buyers show no documented activity purchasing fenyripol hydrochloride as a distinct line item or service offering. Without recent opportunities that actually specify this ingredient as a procurement target, the code does not support a market analysis for business development purposes.